{"DataElement":{"publicId":"3357352","version":"1","preferredName":"Gestational Trophoblastic Tumor Definition Reduced Type","preferredDefinition":"Type of Gestational Trophoblastic Tumor.","longName":"Gest_Defi_Redu_Huma_Type","context":"NRG","contextVersion":"1","DataElementConcept":{"publicId":"3357346","version":"1","preferredName":"Gestational Trophoblastic Tumor Definition","preferredDefinition":"A group of interrelated trophoblastic diseases arising from pregnancy. They are commonly associated with hyperplasia of trophoblasts (TROPHOBLAST) and markedly elevated human CHORIONIC GONADOTROPIN. They include HYDATIDIFORM MOLE, invasive mole (HYDATIDIFORM MOLE, INVASIVE), placental-site trophoblastic tumor (TROPHOBLASTIC TUMOR, PLACENTAL SITE), and CHORIOCARCINOMA. These neoplasms have varying propensities for invasion and spread._A concise explanation of the meaning of a word or phrase or symbol.","longName":"Gest_Defi","context":"NRG","contextVersion":"1","ObjectClass":{"publicId":"2452262","version":"1","preferredName":"Gestational Trophoblastic Tumor","preferredDefinition":"A group of interrelated trophoblastic diseases arising from pregnancy. They are commonly associated with hyperplasia of trophoblasts (TROPHOBLAST) and markedly elevated human CHORIONIC GONADOTROPIN. They include HYDATIDIFORM MOLE, invasive mole (HYDATIDIFORM MOLE, INVASIVE), placental-site trophoblastic tumor (TROPHOBLASTIC TUMOR, PLACENTAL SITE), and CHORIOCARCINOMA. These neoplasms have varying propensities for invasion and spread.","longName":"C4699","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gestational Trophoblastic Tumor","conceptCode":"C4699","definition":"A diverse group of pregnancy-related tumors characterized by excessive proliferation of trophoblasts. It includes gestational choriocarcinoma, epithelioid trophoblastic tumor, placental site trophoblastic tumor, and mixed trophoblastic tumor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0D052842-7AF7-4FD3-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-02-22","endDate":null,"createdBy":"ALAIS","dateCreated":"2006-02-22","modifiedBy":"ONEDATA","dateModified":"2006-02-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2222858","version":"1","preferredName":"Definition","preferredDefinition":"A concise explanation of the meaning of a word or phrase or symbol.","longName":"C42777","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Definition","conceptCode":"C42777","definition":"A concise explanation of the meaning of a word or phrase or symbol.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F6211707-8605-4FE1-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-05-02","endDate":null,"createdBy":"UMLLOADER_EVS","dateCreated":"2005-05-02","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B6D2999F-E9D6-5972-E040-BB89AD430B3F","latestVersionIndicator":"Yes","beginDate":"2012-01-18","endDate":null,"createdBy":"REBOYJ","dateCreated":"2012-01-18","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":" Changed from CTEP to GOG for REBOYJ by script Thu Aug 1 14:45:44 EDT 2013","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3357349","version":"1","preferredName":"Reduced Human Chorionic Gonadotropin Beta Subunit Type","preferredDefinition":"Reduced; made less in size or amount or degree._The beta subunit of human chorionic gonadotropin. It is used as a clinical marker to facilitate early detection of normal pregnancy and significantly contributes to the diagnosis of various pregnancy-related disorders, such as ectopic pregnancy, spontaneous abortion, hydatidiform mole, choriocarcinoma, or Trisomy 21. Further, determination of this marker is immensely helpful to guide curative intervention in testicular cancer. Other possible clinical uses includes as a marker of cancers of the bladder, pancreas, or biliary tract. (Scan J Clin Lab Invest Suppl 1993;216:97-104)_Type; a subdivision of a particular kind of thing.","longName":"Redu_Huma_Type","context":"NRG","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":null,"minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Not Applicable","valueDescription":"Not Applicable","ValueMeaning":{"publicId":"2838911","version":"1","preferredName":"Not Applicable","longName":"2838911","preferredDefinition":"Determination that a value is not relevant in the current context.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not Applicable","conceptCode":"C48660","definition":"Determination of a value is not relevant in the current context.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"62AB59ED-A641-4EBE-E040-BB89AD4348C8","latestVersionIndicator":"Yes","beginDate":"2009-02-11","endDate":null,"createdBy":"LEEB","dateCreated":"2009-02-11","modifiedBy":"CLOHNES","dateModified":"2022-06-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B6D2999F-EA23-5972-E040-BB89AD430B3F","beginDate":"2012-01-18","endDate":null,"createdBy":"REBOYJ","dateCreated":"2012-01-18","modifiedBy":"ONEDATA","dateModified":"2012-01-18","deletedIndicator":"No"},{"value":"Plateau","valueDescription":"Plateau","ValueMeaning":{"publicId":"3357351","version":"1","preferredName":"Plateau","longName":"3357351","preferredDefinition":"<10% decrease in hCG level","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B6D2999F-EA2D-5972-E040-BB89AD430B3F","latestVersionIndicator":"Yes","beginDate":"2012-01-18","endDate":null,"createdBy":"REBOYJ","dateCreated":"2012-01-18","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B6D2999F-EA46-5972-E040-BB89AD430B3F","beginDate":"2012-01-18","endDate":null,"createdBy":"REBOYJ","dateCreated":"2012-01-18","modifiedBy":"ONEDATA","dateModified":"2012-01-18","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3357348","version":"1","preferredName":"Reduced Human Chorionic Gonadotropin Beta Subunit Type","preferredDefinition":"Reduced; made less in size or amount or degree.:The beta subunit of human chorionic gonadotropin. It is used as a clinical marker to facilitate early detection of normal pregnancy and significantly contributes to the diagnosis of various pregnancy-related disorders, such as ectopic pregnancy, spontaneous abortion, hydatidiform mole, choriocarcinoma, or Trisomy 21. Further, determination of this marker is immensely helpful to guide curative intervention in testicular cancer. Other possible clinical uses includes as a marker of cancers of the bladder, pancreas, or biliary tract. (Scan J Clin Lab Invest Suppl 1993;216:97-104):Type; a subdivision of a particular kind of thing.","longName":"C25640:C17479:C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Reduced","conceptCode":"C25640","definition":"Made less in size or amount or degree.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Choriogonadotropin Subunit Beta 3","conceptCode":"C17479","definition":"Choriogonadotropin subunit beta 3 (165 aa, ~18 kDa) is encoded by the human CGB3, CGB5, and CGB8 genes. This protein is involved in the regulation of steroid synthesis during pregnancy.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B6D2999F-E9FE-5972-E040-BB89AD430B3F","latestVersionIndicator":"Yes","beginDate":"2012-01-18","endDate":null,"createdBy":"REBOYJ","dateCreated":"2012-01-18","modifiedBy":"ONEDATA","dateModified":"2012-01-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B6D2999F-EA0F-5972-E040-BB89AD430B3F","latestVersionIndicator":"Yes","beginDate":"2012-01-18","endDate":null,"createdBy":"REBOYJ","dateCreated":"2012-01-18","modifiedBy":"SBR","dateModified":"2013-08-01","changeDescription":" Changed from CTEP to GOG for REBOYJ by script Thu Aug 1 14:45:44 EDT 2013","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"4057943","version":"1","longName":"Disease Site","context":"NRG","ClassificationSchemeItems":[{"publicId":"4104991","version":"1","longName":"GOG-0275","context":"NRG"}]}],"AlternateNames":[{"name":"Gest_Defi_Redu_Huma_Type","type":"USED_BY","context":"NRG"}],"ReferenceDocuments":[{"name":"Does the disease meet the cri","type":"Preferred Question Text","description":"Does the disease meet the criteria for post-molar GTN defined as less than 10% decrease in the hCG level using as a reference the first value in the series of 4 values taken over a 3 week period","url":null,"context":"CTEP"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B6D2999F-EA50-5972-E040-BB89AD430B3F","latestVersionIndicator":"Yes","beginDate":"2012-01-18","endDate":null,"createdBy":"REBOYJ","dateCreated":"2012-01-18","modifiedBy":"TSESU","dateModified":"2023-12-18","changeDescription":"12/18/23_Revised definition to human readable_smt; Changed from CTEP to GOG for REBOYJ by script Thu Aug 1 14:45:44 EDT 2013","administrativeNotes":"12/18/23_Revised definition to human readable_smt","unresolvedIssues":null,"deletedIndicator":"No"}}